Free Trial

Silence Therapeutics (SLN) News Today

Silence Therapeutics logo
Silence Therapeutics: Rising Assets Amid Growing Losses
Silence Therapeutics files automatic ordinary shares offering
Silence Therapeutics plc (SLNCF)
Beyond The Numbers: 7 Analysts Discuss Silence Therapeutics Stock
Is Silence Golden for This Small-Cap Biotech Stock?
Silence Therapeutics PLC ADR SLN
Where Silence Therapeutics Stands With Analysts
Silence Therapeutics Plc (NASDAQ: SLN)
The Latest Analyst Ratings for Silence Therapeutics
Get Silence Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for SLN and its competitors with MarketBeat's FREE daily newsletter.

Your chance to get on the next “60-Second Trade” (Ad)

Ever heard of the “60-Second Trade”? It’s a unique cash flow strategy that lets regular traders target anywhere from $100 to a couple of thousand in extra cash flow in as little as 7 days… In on Monday, out on Friday!

Just head over here!

SLN Media Mentions By Week

SLN Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

SLN
News Sentiment

0.00

0.59

Average
Medical
News Sentiment

SLN News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

SLN Articles
This Week

1

0

SLN Articles
Average Week

Get Silence Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for SLN and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (LON:SLN) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners